Keywords: پراسوگرل; P2Y12 antagonist; Prasugrel; Aspirin; Myocardial infarction; Miniature pig;
مقالات ISI پراسوگرل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پراسوگرل; Prasugrel; Intra-stent tissue; Optical coherence tomography; Acute phase; Platelet reactivity;
Keywords: پراسوگرل; Angioplasty; clopidogrel; distal protection; drug-eluting stent; intravascular ultrasound; laser; MRCP; optical coherence tomography; percutaneous coronary intervention; prasugrel; pressure wire; radial; rotablation; stent; thrombectomy; ticagrelor;
Keywords: پراسوگرل; Myocardial infarction; Clopidogrel; Prasugrel; Koreans;
Keywords: پراسوگرل; Prasugrel; P2Y12 receptor; Contractile function; Membrane potential; Nitric oxide;
Keywords: پراسوگرل; Antiplatelets; Prasugrel; Ticagrelor; Acute coronary syndrome; Prognosis;
Keywords: پراسوگرل; Platelets; Acute coronary syndromes; Prasugrel;
Keywords: پراسوگرل; Prasugrel; Clopidogrel; Chronic kidney disease; Platelet reactivity;
Keywords: پراسوگرل; Acute coronary syndromes; Antiplatelet treatment; Guidelines; Myocardial infarction; Percutaneous Coronary intervention; Clopidogrel; Ticagrelor; Prasugrel;
Keywords: پراسوگرل; Médicaments antiplaquettaires; Clopidogrel; Prasugrel; Aspirine; Ticagrelor; Transfusion plaquettaire; Hémorragie; Antidote; P2Y12; Antiplatelet agents; Clopidogrel; Prasugrel; Aspirine; Ticagrelor; Platelet transfusion; Bleeding; Antidote; P2Y12;
Keywords: پراسوگرل; Acute coronary syndrome; Optical coherence tomography; Prasugrel; Stent; Thrombus;
Keywords: پراسوگرل; Prasugrel; High on-treatment platelet reactivity; Acute myocardial infarction; Major adverse cardiovascular events;
Keywords: پراسوگرل; Pretreatment; Preloading; Clopidogrel; Prasugrel; Ticagrelor; Cangrelor;
Keywords: پراسوگرل; aortic stenosis; surgical aortic valve replacement; transcatheter aortic valve replacement; balloon-inflatable prosthesis; self-inflating prosthesis; surgical risk; Society of Thoracic Surgeons; Cardiothoracic Surgical Trials Network; PARTNER trials; NOTI
Keywords: پراسوگرل; Ticagrelor; Prasugrel; Clopidogrel; Neointima formation; Endothelium; Drug-eluting stents;
Keywords: پراسوگرل; Clopidogrel; Prasugrel; Ticagrelor; Dual antiplatelet therapy; Coronary stenting; Bleeding; Prediction; VerifyNow assay;
Keywords: پراسوگرل; High residual platelet reactivity; In-stent thrombosis; Prasugrel; Ticagrelor; Acute coronary syndrome;
Keywords: پراسوگرل; Thienopyridines; Hypersensitivity; Ticlopidine; Clopidogrel; Prasugrel; Urticaria; Arthritis; Exanthema;
Keywords: پراسوگرل; Novel oral antiplatelet; NOAP; prasugrel; ticagrelorADP, Adenosine diphosphate; CASP, Critical Appraisal Skills Programme; FDA, Food and Drug Administration; MI, Myocardial infarction; NOAP, Novel oral antiplatelet; SDCEP, Scottish Dental Clinical Effecti
Keywords: پراسوگرل; Prasugrel; P2Y12 receptor antagonist; Pharmacokinetics; Inhibition of platelet aggregation; Japanese healthy subjects;
Keywords: پراسوگرل; Ticagrelor; Clopidogrel; Prasugrel; Drug resistance; Percutaneous coronary intervention;
Keywords: پراسوگرل; Antiplatelet; Aspirin; Microminipig; Miniature Pig; Platelet Aggregation; Prasugrel;
Keywords: پراسوگرل; Thrombosis; Platelet aggregation; Neointimal hyperplasia; Prasugrel; Thienopyridine; P2Y12 receptor;
Keywords: پراسوگرل; ACS; acute coronary syndrome; CI; confidence interval; CABG; coronary artery bypass graft; HR; hazard ratio; LD; loading dose; MACE; major adverse cardiovascular events; MD; maintenance dose; PCI; percutaneous coronary intervention; PRASFIT-ACS; PRASugrel
Keywords: پراسوگرل; Acute coronary syndrome; Myocardial infarction; Unstable angina; Clopidogrel; Ticagrelor; Prasugrel;
Keywords: پراسوگرل; Medicamento antiplaquetario; Aspirina; Clopidogrel; Prasugrel; Ticagrelor; Resistencia biológica
Keywords: پراسوگرل; anticoagulant; antiplatelet; apixaban; blood thinners; dabigatran; dermatologic surgery; dietary supplements; prasugrel; rivaroxaban; ticagrelorADP, adenosine diphosphate; AF, atrial fibrillation; CVA, cerebrovascular accident; FDA, Food and Drug Administ
Keywords: پراسوگرل; Clopidogrel resistance; Platelet reactivity; Stent thrombosis; Prasugrel; Ticagrelor;
Keywords: پراسوگرل; Sickle cell disease; Adenine nucleotide; Platelet; P2Y12 antagonist; Prasugrel;
Keywords: پراسوگرل; Prasugrel; Cilostazol; Platelet function tests; ST elevation myocardial infarction;
Keywords: پراسوگرل; Aspirina; Clopidogrel; Genética; Individualización; Factores de riesgo; Resistencia; Guías; Prasugrel; TicagrelorAspirin; Clopidogrel; Genetics; Individualization; Risk factors; Resistance; Guidelines; Prasugrel; Ticagrelor
Keywords: پراسوگرل; ACS; acute coronary syndrome; ADP; adenosine diphosphate; ADR; adverse drug reaction; CABG; coronary artery bypass surgery; CI; confidence interval; CV; cardiovascular; CYP; cytochrome p450; HOPR; high on-treatment platelet reactivity; HR; hazard ratio; H
Keywords: پراسوگرل; Platelet function testing; Individualized antiplatelet treatment; Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome;
Keywords: پراسوگرل; Platelet reactivity; Clopidogrel; Prasugrel; Ethnicity; Acute coronary syndrome;
Keywords: پراسوگرل; Acute coronary syndrome; Platelet reactivity; Clopidogrel; Prasugrel;
Keywords: پراسوگرل; Ticlopidine; Clopidogrel; Clopidogrel carboxylate; Prasugrel; Myelotoxicity; Granulocytes; Lymphocytes;
Keywords: پراسوگرل; Platelet aggregation; Ticagrelor; Prasugrel; Bleeding; Myocardial infarction
Pharmacogenomic Testing to Select Antiplatelet Therapyâ
Keywords: پراسوگرل; acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor;
Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromesâ
Keywords: پراسوگرل; de-escalation; myocardial infarction; outcome; prasugrel; primary percutaneous coronary intervention; ticagrelor;
The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis
Keywords: پراسوگرل; P2Y12 inhibitor; Prasugrel; Ticagrelor; Acute coronary syndrome (ACS); Meta-regression; Mortality;
Asociación entre las escalas de riesgo isquémico y hemorrágico y el uso de los nuevos inhibidores del P2Y12 en pacientes con sÃndrome coronario agudo
Keywords: پراسوگرل; GRACE; CRUSADE; Prasugrel; Ticagrelor y sÃndrome coronario agudo; GRACE; CRUSADE; Prasugrel; Ticagrelor and acute coronary syndromes; SCA; sÃndrome coronario agudo;
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal
Keywords: پراسوگرل; acetylsalicylic acid; clopidogrel; prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban; warfarin; heparin; low molecular weight heparin; proton pump inhibitors; Bleeding; Chronic kidney disease; Management; Risk;
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers
Keywords: پراسوگرل; adenosine; endothelial function; P2Y12 inhibitors; prasugrel; ticagrelor; ACS; acute coronary syndrome; ANOVA; analysis of variance; ENT1; equilibrative nucleoside transporter 1; FMD; flow-mediated dilation; LD; loading dose; MD; maintenance dose; RHI; re
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Keywords: پراسوگرل; Anemia; Acute coronary syndromes; Prognosis; Ticagrelor; Prasugrel;
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
Keywords: پراسوگرل; ACS; acute coronary syndrome; ACCOAST trial; Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time of Diagnosis in Patients with Non-ST Elevation Myocardial Infarction trial; ACUITY; acute catheterization
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS
Keywords: پراسوگرل; GuÃa de práctica clÃnica; Ácido acetilsalicÃlico; Clopidogrel; Ticagrelor; Prasugrel; Tratamiento antiagregante plaquetario doble; SÃndrome coronario agudo; CirugÃa de revascularización coronaria; Enfermedad coronaria; Stents; Stent farmacoactivo;
P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial
Keywords: پراسوگرل; Ticagrelor; Prasugrel; Fibrinolysis; Acute myocardial infarction;
Genetic Determinants of P2Y12 Inhibitors and Clinical Implications
Keywords: پراسوگرل; Clopidogrel; Prasugrel; Ticagrelor; Genotype; CYP2C19; Pharmacogenomics;
Randomized Comparison of Oral P2Y12-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor
Keywords: پراسوگرل; cangrelor; clopidogrel; percutaneous coronary intervention; platelet reactivity; prasugrel; ticagrelor; ADP; adenosine diphosphate; AU à min; aggregation units per min; PCI; percutaneous coronary intervention;
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Keywords: پراسوگرل; aspirin; cangrelor; clopidogrel; prasugrel; ticagrelor; vorapaxar; ACS; acute coronary syndromes; CABG; coronary artery bypass graft; CAD; coronary artery disease; COX; cyclooxygenase; DAPT; dual antiplatelet therapy; ICH; intracranial hemorrhage; MI; myo